Abstract
Highlights: People living with HIV do not achieve an optional immune reconstitution despite the sustained virologic suppression. Circulating CD4 T cells fail to replenish their lymphoid tissue counterparts in people living with HIV. Irrespective of ART, coffin hyperactivation and impaired T cell mobility persist in people living with HIV. Cofilin may represent a novel therapeutic target to restore T cell mobility in people living with HIV.
Funding Information
  • Bill and Melinda Gates Foundation (OPP1035237)
  • National Institute of Allergy and Infectious Diseases (R01AI117835, R21AI104268)